ALLARITY THERAPEUTICS INC (ALLR)       1.14  +0.04 (+3.64%)

1.14  +0.04 (+3.64%)

US0167441049 - Common Stock

News Image
8 days ago - Allarity Therapeutics, Inc.

Allarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors

Press release Cambridge, MA U.S.A. (September 26, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage...

News Image
18 days ago - Allarity Therapeutics, Inc.

Allarity Therapeutics to Present at Ladenburg Thalmann Healthcare Conference

Press release Cambridge, MA U.S.A. (September 16, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage...

News Image
22 days ago - Allarity Therapeutics, Inc.

Allarity Therapeutics Announces Appointment of New Auditor

Press release     Cambridge, MA U.S.A. (September 12, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage...

News Image
a month ago - Allarity Therapeutics, Inc.

Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

Press release        Cambridge, MA U.S.A. (August 26, 2022) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage...

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're starting off the day with an overview of the biggest pre-market stock movers for Thursday and the news behind that movement!

News Image
2 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday and what's moving them!

News Image
2 months ago - Allarity Therapeutics, Inc.

Allarity Therapeutics Refocuses Oncology Pipeline Strategy Towards Combination Therapies

New strategy aligns with ongoing shift in oncology standard-of-caretowards combination therapies Combination therapy focus expected to improve the...

News Image
3 months ago - Allarity Therapeutics, Inc.

Allarity Therapeutics Announces Executive Leadership Transition

  Board Appoints James G. Cullem, J.D., to Interim Chief Executive Officer,Joan Y. Brown, CPA, to Interim Chief Financial Officer Press release      ...

News Image
4 months ago - Allarity Therapeutics, Inc.

Allarity Therapeutics Strengthens Scientific Advisory Board with Appointment of Distinguished Oncologist Roberto Pili, M.D.

Cambridge, MA U.S.A. (June 15, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel...

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning! We're preparing for another busy day of trading with a breakdown of the biggest pre-market stock movers for Friday!

News Image
4 months ago - Allarity Therapeutics, Inc.

Allarity Therapeutics Reports First Quarter 2022 Financial Results

Cambridge, MA U.S.A. (May 27, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel...